Executive Summary
Welcome to the September 2026 edition of the Global Dental Industry Briefing. This month brings revolutionary shifts across clinical technology, regulatory approvals, global market expansions, and corporate investments. Key highlights featured in this summary include:
-
Pearl Releases Second Opinion 3D: FDA-Cleared CBCT AI Commercialized for General Dentists
-
SprintRay Launches MIDAS Restore: FDA 510(k)-Cleared Glass-Ceramic & Zirconia Resin
-
Dental Robotics Secures Seed Funding: AI Autonomous Suction Robot Takes Shape
-
FDI World Dental Congress 2026 Concludes in Prague: Over 8,000 Global Attendees Gather
-
EAO Congress 2026 Convenes in Lisbon: Spotlighting Peri-Implantitis and Digital Protocols
-
Yucera Completes Series B Funding: Tens of Millions RMB Raised for Dental Material Innovator
-
Medprin Receives NMPA Clearance: Absorbable Oral Repair Membrane Approved in China
-
Global Osseointegrated Implant Market Report: Projected to Reach $20.78 Billion by 2035
-
Clinical Research Updates: 5-Year Zirconia Implant Survival and Cu-Doped β-TCP Coating Advances
1. Pearl Releases Second Opinion 3D: FDA-Cleared CBCT AI Commercialized for General Dentists
On September 3, 2026, Pearl officially launched Second Opinion 3D, marking the first time its FDA-cleared 3D dental image analysis technology became commercially available to general practitioners across the United States and Canada.
The software automatically detects and segments key anatomical structures in Cone Beam Computed Tomography (CBCT) scans, including the mandible, maxilla, nasal cavity, airway, inferior alveolar nerve canals, and individual teeth. Beyond diagnostic visualization, the platform enables one-click expert oral and maxillofacial radiologist report requests and automatically translates 3D clinical findings into standardized documentation for insurance claims. With this release, Pearl solidifies its position as a pioneer in AI-driven 2D and 3D dental diagnostics.
2. SprintRay Launches MIDAS Restore: FDA 510(k)-Cleared Glass-Ceramic & Zirconia Resin
On September 1, 2026, SprintRay commercially debuted MIDAS Restore in the U.S. market. Specially formulated for the MIDAS digital press machine, MIDAS Restore is a definitive restoration resin filled with glass-ceramic and zirconia particles.
Holding FDA 510(k) clearance (K260661), the resin is indicated for definitive crowns, inlays, onlays, and veneers. The product represents a major breakthrough in chairside 3D printing, bridging the gap between additive manufacturing speeds and long-term restorative durability.
3. Dental Robotics Secures Seed Funding for AI Autonomous Suction Robot
On September 21, 2026, South Korean startup Dental Robotics announced the successful closure of its seed funding round.
The company is developing an artificial intelligence-driven autonomous suction robot engineered to perform real-time fluid aspiration and maintain clear surgical sightlines during complex oral procedures. By automating suction management, the technology aims to reduce operational strain on dental assistants and streamline workflow efficiency in surgical operatories.
4. FDI World Dental Congress 2026 Successfully Held in Prague
From September 4 to 7, 2026, the FDI World Dental Congress 2026 took place at the O₂ Arena & O₂ Universum in Prague, Czech Republic. Marking the first time the country hosted the global flagship event, the congress attracted over 8,000 participants from more than 90 countries.
Spanning an exhibition footprint exceeding 3,000 square meters, the congress showcased cutting-edge advancements in artificial intelligence, digital workflow integration, and emerging restorative materials, highlighting the future direction of global oral healthcare.
5. EAO Congress 2026 Convenes in Lisbon
From September 24 to 26, 2026, the European Association for Osseointegration (EAO) held its annual congress in Lisbon, Portugal.
The world-leading implantology meeting gathered global experts to discuss critical advancements in peri-implantitis prevention and management, immediate loading protocols, and fully integrated digital implantology workflows, emphasizing evidence-based clinical methodologies.
6. Yucera (Shenzhen Yurucheng Dental Material) Completes Series B Funding Round
On September 11, 2026, Shenzhen-based dental material and equipment innovator Yucera (Shenzhen Yurucheng Dental Material Co., Ltd.) successfully finalized a Series B financing round raising tens of millions of RMB.
The investment was co-led by Suikai Investment, Zhuhai High-Tech Golden Investment, and Aeonmed Group, with Hanyu Capital serving as the exclusive financial advisor. The capital injection will primarily fund further research and development in zirconia materials, digital CAD/CAM restorative equipment, and global market channel expansion.
7. Medprin Obtains NMPA Clearance for Absorbable Oral Repair Membrane
According to the National Medical Products Administration (NMPA) approval notice dated September 24, 2026, Guangzhou Medprin Regenerative Medical Technologies Co., Ltd. officially secured a Class III medical device registration certificate (Registration No.: 国械注准20263172029, approved September 23, 2026) for its proprietary Absorbable Oral Repair Membrane.
This regulatory milestone enables Medprin to expand its regenerative material footprint into guided bone regeneration (GBR) and soft tissue repair procedures across mainland China.
8. Global Osseointegrated Implant Market Projected to Reach $20.78 Billion by 2035
An updated industry market report released on September 15, 2026, indicated that the global osseointegrated dental implant market was valued at $9.51 billion in 2025 and is projected to expand to $20.78 billion by 2035, displaying a Compound Annual Growth Rate (CAGR) of 8.72%.
Key growth catalysts include an increasing global aging population, rising patient awareness of fixed restorative options, and the mainstream adoption of guided digital implantology.
9. Recent Clinical Studies: Zirconia Survival Rates & Copper-Doped Coatings
-
10-Year Zirconia Implant Performance Data: A retrospective study published in 2026 evaluating 80 ceramic implants across 45 patients demonstrated a 5-year cumulative survival rate of 83.8% and a 10-year survival rate of 73.8%. While noting clear aesthetic benefits in the anterior zone, researchers underscored the necessity of monitoring long-term mechanical stress to prevent structural fractures.
-
Copper-Doped β-TCP Coating Innovations: Research published in the September 2026 issue of Materials Science and Engineering: C revealed that copper-doped beta-tricalcium phosphate (β-TCP) implant coatings significantly enhance osseointegration and antibacterial behavior in vivo. Controlled copper ion release stimulated angiogenesis while effectively inhibiting Staphylococcus aureus biofilm formation, providing a novel methodology for surface modification in dental implantology.